135 related articles for article (PubMed ID: 28393404)
1. Patients with high c-MYC-expressing squamous cell carcinomas of the tongue show better survival than those with low- and medium-expressing tumours.
Strindlund K; Troiano G; Sgaramella N; Coates PJ; Gu X; Boldrup L; Califano L; Fahraeus R; Muzio LL; Ardito F; Colella G; Tartaro G; Franco R; Norberg-Spaak L; Saadat M; Nylander K
J Oral Pathol Med; 2017 Nov; 46(10):967-971. PubMed ID: 28393404
[TBL] [Abstract][Full Text] [Related]
2. Expression of C-Myc mRNA in squamous cell carcinoma of the tongue.
Vora HH; Shah NG; Trivedi TI; Goswami JV; Shukla SN; Shah PM
J Surg Oncol; 2007 Jan; 95(1):70-8. PubMed ID: 17192869
[TBL] [Abstract][Full Text] [Related]
3. Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance.
Riva C; Lavieille JP; Reyt E; Brambilla E; Lunardi J; Brambilla C
Eur J Cancer B Oral Oncol; 1995 Nov; 31B(6):384-91. PubMed ID: 8746269
[TBL] [Abstract][Full Text] [Related]
4. [The experimental study on telomerase activity and expression of p53 and c-myc genes in tongue cancer].
Fang Z; Li H; Wang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Aug; 21(4):274-6. PubMed ID: 14513581
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract][Full Text] [Related]
6. MicoRNA-451 is a novel tumor suppressor via targeting c-myc in head and neck squamous cell carcinomas.
Wang H; Zhang G; Wu Z; Lu B; Yuan D; Li X; Lu Z
J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C216-21. PubMed ID: 26506880
[TBL] [Abstract][Full Text] [Related]
7. Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma.
Kelner N; Rodrigues PC; Bufalino A; Fonseca FP; Santos-Silva AR; Miguel MC; Pinto CA; Leme AF; Graner E; Salo T; Kowalski LP; Coletta RD
Head Neck; 2015 Apr; 37(4):479-86. PubMed ID: 24677273
[TBL] [Abstract][Full Text] [Related]
8. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813
[TBL] [Abstract][Full Text] [Related]
9. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of c-MYC in esophageal squamous cell carcinoma.
Lian Y; Niu X; Cai H; Yang X; Ma H; Ma S; Zhang Y; Chen Y
Tumour Biol; 2017 Jul; 39(7):1010428317715804. PubMed ID: 28671049
[TBL] [Abstract][Full Text] [Related]
11. Four PTEN-targeting co-expressed miRNAs and ACTN4- targeting miR-548b are independent prognostic biomarkers in human squamous cell carcinoma of the oral tongue.
Berania I; Cardin GB; Clément I; Guertin L; Ayad T; Bissada E; Nguyen-Tan PF; Filion E; Guilmette J; Gologan O; Soulieres D; Rodier F; Wong P; Christopoulos A
Int J Cancer; 2017 Dec; 141(11):2318-2328. PubMed ID: 28779483
[TBL] [Abstract][Full Text] [Related]
12. The role of miR-21 in proliferation and invasion capacity of human tongue squamous cell carcinoma in vitro.
Wang Y; Zhu Y; Lv P; Li L
Int J Clin Exp Pathol; 2015; 8(5):4555-63. PubMed ID: 26191145
[TBL] [Abstract][Full Text] [Related]
13. Global DNA hypomethylation is associated with the development and poor prognosis of tongue squamous cell carcinoma.
Chen HC; Yang CM; Cheng JT; Tsai KW; Fu TY; Liou HH; Tseng HH; Lee JH; Li GC; Wang JS; Hou YY; Weng TJ; Ger LP
J Oral Pathol Med; 2016 Jul; 45(6):409-17. PubMed ID: 26525607
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of INSR/IGF1R by C-myc promotes TSCC tumorigenesis and metastasis through the NF-κB pathway.
Sun J; Lu Z; Deng Y; Wang W; He Q; Yan W; Wang A
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1873-1882. PubMed ID: 29518496
[TBL] [Abstract][Full Text] [Related]
15. Nuclear DNA content and p53 overexpression in stage I squamous cell carcinoma of the tongue compared with advanced tongue carcinomas.
Högmo A; Kuylenstierna R; Lindholm J; Nathansson A; Auer G; Munck-Wikland E
Mol Pathol; 1998 Oct; 51(5):268-72. PubMed ID: 10193521
[TBL] [Abstract][Full Text] [Related]
16. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma.
Qiu K; Huang Z; Huang Z; He Z; You S
Arch Oral Biol; 2016 Jun; 66():92-7. PubMed ID: 26943814
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-myc oncoprotein in laryngeal squamous cell carcinoma.
Krecicki T; Fraczek M; Jelen M; Zatonski T; Szkudlarek T; Dus D
Acta Otolaryngol; 2004 Jun; 124(5):634-7. PubMed ID: 15267185
[TBL] [Abstract][Full Text] [Related]
18. SOD2 is a C-myc target gene that promotes the migration and invasion of tongue squamous cell carcinoma involving cancer stem-like cells.
Liu Z; He Q; Ding X; Zhao T; Zhao L; Wang A
Int J Biochem Cell Biol; 2015 Mar; 60():139-46. PubMed ID: 25578561
[TBL] [Abstract][Full Text] [Related]
19. Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients.
Knopf A; Lempart J; Bas M; Slotta-Huspenina J; Mansour N; Fritsche MK
Oncotarget; 2015 Feb; 6(5):3443-51. PubMed ID: 25633809
[TBL] [Abstract][Full Text] [Related]
20. Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue.
Häyry V; Mäkinen LK; Atula T; Sariola H; Mäkitie A; Leivo I; Keski-Säntti H; Lundin J; Haglund C; Hagström J
Br J Cancer; 2010 Mar; 102(5):892-7. PubMed ID: 20145620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
